USPTO trademark

PARZYMIO

AllowedUSPTOWord markClass 5

"PARZYMIO" is a word mark owned by AstraZeneca AB, filed at the USPTO on March 17, 2026. It has been allowed and covers class 5 (Pharmaceuticals).

View AstraZeneca AB portfolioGet this data via the API
Official USPTO record
PARZYMIO trademark as filed
As filed with the USPTO
Status
Allowed
Since September 1, 2026
Filed
March 17, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99707733
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns PARZYMIO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

AstraZeneca AB

Sodertalje, Sweden

6,107 trademarks in the portfolioView company

Representative

Leonid Rakitin

AstraZeneca Pharmaceuticals LP

Goods and services

What the mark covers

The products and services PARZYMIO is filed for, grouped by Nice class.

  • Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Vaccines; Antibodies for medical purposes

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Noa e-mailed - sou required from applicant
  2. Teas change of correspondence received
  3. Attorney/dom.rep.revoked and/or appointed
  4. Teas revoke/app/change addr of atty/dom rep received
  5. Official gazette publication confirmation e-mailed
  6. Published for opposition
  7. Notification of notice of publication e-mailed
  8. Approved for pub - principal register
  9. Assigned to examiner
  10. Application filing receipt mailed

2 earlier steps on the official record.

FAQ

About PARZYMIO

Who owns the trademark "PARZYMIO"?

The USPTO trademark "PARZYMIO" (application 99707733) is owned by AstraZeneca AB.

What is the status of "PARZYMIO"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull PARZYMIO and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d3f15-3a19-724e-a384-ebc6ebfbf9af
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d3f15-3a19-724e-a384-ebc6ebfbf9af",
  "object": "trademark",
  "mark_text": "PARZYMIO",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99707733",
  "filing_date": "2026-03-17",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "AstraZeneca AB",
      "entity_id": "ent_019eb700-571d-718e-bf3d-80fe37712629"
    }
  ]
}